Cargando…

Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial

INTRODUCTION: Molecular characterisation of tumours is increasing personalisation of cancer therapy, tailored to an individual and their cancer. FOCUS4 is a molecularly stratified clinical trial for patients with advanced colorectal cancer. During an initial 16-week period of standard first-line che...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richman, Susan D, Adams, Richard, Quirke, Phil, Butler, Rachel, Hemmings, Gemma, Chambers, Phil, Roberts, Helen, James, Michelle D, Wozniak, Sue, Bathia, Riya, Pugh, Cheryl, Maughan, Timothy, Jasani, Bharat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717430/ https://www.ncbi.nlm.nih.gov/pubmed/26350752 http://dx.doi.org/10.1136/jclinpath-2015-203097

Ejemplares similares

FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing
por: Richman, Susan D, et al.
Publicado: (2023)

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
por: Maughan, T S, et al.
Publicado: (2014)

Intra-tumoral Heterogeneity of KRAS and BRAF Mutation Status in Patients with Advanced Colorectal Cancer (aCRC) and Cost-Effectiveness of Multiple Sample Testing
por: Richman, Susan D., et al.
Publicado: (2011)

The Promise and the Hype of ‘Personalised Medicine’
por: Maughan, Tim
Publicado: (2017)

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
por: Schiavone, Francesca, et al.
Publicado: (2019)

Personalised analytics for rare disease diagnostics
por: Anderson, Denise, et al.
Publicado: (2019)

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial
por: Adams, Richard, et al.
Publicado: (2017)

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
por: Seymour, Matthew T, et al.
Publicado: (2013)

Analytics: the agile way
por: Simon, Phil
Publicado: (2017)

The effect of personalised versus non-personalised study invitations on recruitment within the ENGAGE feasibility trial: an embedded randomised controlled recruitment trial
por: Thiblin, Ella, et al.
Publicado: (2022)

Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer
por: Brown, Louise C, et al.
Publicado: (2022)

Confirmation that somatic mutations of beta‐2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial
por: Barrow, Paul, et al.
Publicado: (2019)

HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials
por: Richman, Susan D, et al.
Publicado: (2016)

From Rosalind Franklin to Barack Obama: Data Sharing Challenges and Solutions in Genomics and Personalised Medicine
por: Lawler, Mark, et al.
Publicado: (2017)

An embedded randomised controlled retention trial of personalised text messages compared to non-personalised text messages in an orthopaedic setting
por: Mitchell, Alex S., et al.
Publicado: (2021)

New tricks with old dogs: personalised medicine and clinical trials
por: Koziol, J A
Publicado: (2011)

Study within a trial (SWAT) protocol. Investigating the effect of personalised versus non-personalised study invitations on recruitment: An embedded randomised controlled recruitment trial
por: Woodford, Joanne, et al.
Publicado: (2020)

The effect of mobile personalised texting versus non-personalised texting on the caries risk of underprivileged adults: a randomised control trial
por: Nishi, Makiko, et al.
Publicado: (2019)

Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design
por: Garin, Etienne, et al.
Publicado: (2020)

Personalised Medicine Using N-of-1 Trials: Overcoming Barriers to Delivery
por: Chalmers, Iain, et al.
Publicado: (2019)

A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment
por: Viratham Pulsawatdi, Amélie, et al.
Publicado: (2020)

Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trial
por: de Hosson, L. D., et al.
Publicado: (2019)

Questionnaires in clinical trials: guidelines for optimal design and administration
por: Edwards, Phil
Publicado: (2010)

Study designs for clinical trials applied to personalised medicine: a scoping review
por: Superchi, Cecilia, et al.
Publicado: (2022)

Quorum-sensing, intra- and inter-species competition in the staphylococci
por: Williams, Paul, et al.
Publicado: (2023)

Series of virtual light therapy interventions for fatigue: a feasibility pilot study protocol for a series of personalised (N-of-1) trials
por: Butler, Mark, et al.
Publicado: (2022)

Personalised diet
Publicado: (2011)

Personalised Ecology
por: Gaston, Kevin J., et al.
Publicado: (2018)

The impact of hypothetical PErsonalised Risk Information on informed choice and intention to undergo Colorectal Cancer screening colonoscopy in Scotland (PERICCS)—a randomised controlled trial
por: Digby, Jayne, et al.
Publicado: (2020)

Personalisation schemes in social care: are they growing social and health inequalities?
por: Malbon, Eleanor, et al.
Publicado: (2019)

The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology
por: Schöniger, Sandra, et al.
Publicado: (2022)

Brilliant speed reading: whatever you need to read, however you want to read it : twice as quickly
por: Chambers, Phil
Publicado: (2013)

Improve your speed reading skills
por: Chambers, Phil
Publicado: (2015)

Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone
por: ten Hoorn, Sanne, et al.
Publicado: (2021)

Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations
por: Gollins, Simon, et al.
Publicado: (2017)

Exercise and manual auricular acupuncture: a pilot assessor-blind randomised controlled trial. (The acupuncture and personalised exercise programme (APEP) Trial)
por: McDonough, SM, et al.
Publicado: (2008)

Impact of Personalised Patient Education on Bowel Preparation for Colonoscopy: Prospective Randomised Controlled Trial
por: Elvas, Luís, et al.
Publicado: (2017)

Smart Medication Adherence Monitoring in Clinical Drug Trials: A Prerequisite for Personalised Medicine?
por: Zijp, Tanja R., et al.
Publicado: (2019)

The validity of the Royal College of Pathologists’ colorectal cancer minimum dataset within a population
por: Maughan, N J, et al.
Publicado: (2007)

Trial of Optimal Personalised Care After Treatment for Gynaecological cancer (TOPCAT-G): a study protocol for a randomised feasibility trial
por: Pye, Kirstie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qacqep257h9hjh1o27rs3h31fp